Senti Biosciences Holdings annual return on equity
2022
2023
2024
2025
Senti Biosciences Holdings Return on Equity (ROE) Growth & History (SNTI)
Senti Biosciences Holdings's return on equity was −393.35% for fiscal 2025.
View full Senti Biosciences Holdings company overviewSenti Biosciences Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −393.35% | −279.29 pp |
| 2024 | 2024-12-31 | −114.06% | −40.87 pp |
| 2023 | 2023-12-31 | −73.19% | +663.37 pp |
| 2022 | 2022-12-31 | −736.56% | — |
Senti Biosciences Holdings quarterly return on equity
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −103.53% | −59.09 pp |
| Q4 2025 | 2025-12-31 | −211.04% | −208.11 pp |
| Q3 2025 | 2025-09-30 | −110.62% | −14.62 pp |
| Q2 2025 | 2025-06-30 | −47.14% | −24.79 pp |
| Q1 2025 | 2025-03-31 | −44.44% | −24.75 pp |
| Q4 2024 | 2024-12-31 | −2.93% | +91.91 pp |
| Q3 2024 | 2024-09-30 | −95.99% | −79.44 pp |
| Q2 2024 | 2024-06-30 | −22.35% | −4.52 pp |
| Q1 2024 | 2024-03-31 | −19.69% | −4.06 pp |
| Q4 2023 | 2023-12-31 | −94.84% | −51.34 pp |
| Q3 2023 | 2023-09-30 | −16.55% | −5.25 pp |
| Q2 2023 | 2023-06-30 | −17.83% | +53.35 pp |
| Q1 2023 | 2023-03-31 | −15.63% | — |
| Q4 2022 | 2022-12-31 | −43.50% | — |
| Q3 2022 | 2022-09-30 | −11.30% | — |
| Q2 2022 | 2022-06-30 | −71.18% | — |
Senti Biosciences Holdings return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Senti Biosciences Holdings's return on equity increased from −736.56% to −393.35%, a change of +343.20 percentage points. The latest reported quarter, Q1 2026, shows −103.53%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Senti Biosciences Holdings source filings ↗